Word mark

Trademark: 'Hemoteq' 
Hemoteq AG
European Community Trademark, no. 002414522, Word mark

 

On 17. 10. 2001 the community trademark application no. 002414522 was filed for Hemoteq (Word mark) by Hemoteq AG before the OAMI.The goods and services in respect of which registration of the trademark was sought are in classes 1, 10, 40 and 42. The current status of the trademark is registration cancellation pending.

Status is 'Registration cancellation pending'
A cancellation request has been filed against the registration of this Community Trade Mark. The cancellation may be based on bad faith, formality grounds or on earlier rights. The examination of the cancellation until a final decision may take some time.

Registered4. 1. 2006
Expiry date17. 10. 2021
Nice classes1, 10, 40, 42

 
 

You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.

 

Owner

Hemoteq AG
Adenauerstr. 15
52146 Würselen
DE

 

If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89

Representative

ABK PATENT AND TRADEMARK ATTORNEYS
Jasminweg 9
14052 Berlin
DE

 

If the data above is not correct, then please choose Update.

 
 

Nice classes

1  Chemical substance, especially organic macromolecular substances for the coating of artificial and natural surfaces; heparin, heparin derivatives and organic macromolecular substances with antithrombotic and/or anti-coagulative properties, especially for the coating of artificial surfaces for the intra- and extracorporeal circulation and for the coating of natural surfaces and surgical implants.

10  Hearts, heart parts, lungs, arteries, veins, aortas of mammals, especially hearts of pigs, heart valves of pigs, corpse veins, artificial heart valves, hearts, lungs, arteries, veins, aortas; articles for medical use for the contact with blood, especially tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and the extracorporeal circulation except vascular filtration devices; surgical implants ,excluding vascular filtration devices; anti-thrombotic and/or anti-coagulative surgical implants, excluding vascular filtration devices; artificial and natural surfaces for medical purposes, especially for the intra- and extracorporal circulation, excluding vascular filtration devices; artificial and natural surfaces and surgical implants coated with heparin, heparin derivatives or macromolecular agents, especially natural hearts, heart valves, lungs, arteries, veins, aortas of mammals and artificial heart valves, hearts, lungs, arteries, veins, aortas except vascular filtration devices; articles for medical use and for the contact with blood coated with heparin, heparin derivatives or macromolecular agents, especially tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and the extracorporeal circulation except vascular filtration devices.

40  Commissioned research work and commissioned development work in the field of surrogates for blood and blood substitutes, blood products and blood-compatible materials and blood-compatible implants; commissioned coating work of artificial surfaces and surgical implants with biopolymers, especially with heparin, heparin derivatives or anti-thrombotic and/or anti-coagulative macromolecular substances; commissioned research work, commissioned development work and advisory services in the field of the coating of artificial surfaces, surgical implants and parts for the cardiovascular system and the extracorporeal circulation, especially coatings with heparin, heparin derivatives or anti-thrombotic and/or anticoagulative macromolecular substances.

42  Services of a research company in the field of biochemical, pharmaceutical and medicine-technological research work, especially in the field of surrogates for blood, blood substitutes, blood products and blood-compatible materials and blood-compatible implants and blood-compatible parts for the cardiovascular system and the extracorporeal circulation.

 
 
 

Records history

 
17.10.2021 Expiry
Expiry date of the trademark 002414522 Hemoteq
9.12.2016 The current state is Registration cancellation pending
Current state
31.10.2016 Published
Revocation and declaration of invalidity - Application for revocation or for a declaration of invalidity
9.11.2011 Trade mark renewed
D.1 Renewal of a mark
16.6.2008 Published
Representative - Change of name and professional address
19.5.2008 Published
Representative - Change of name and professional address
13.8.2007 Published
Proprietor - Change of name and address
4.1.2006 Registration
Registration of the trademark 002414522 Hemoteq
26.6.2003 Not to be published
Representative - Replacement of representative
16.4.2003 Registered
Representative - Change of name and professional address
17.10.2001 Application
Application of the trademark 002414522 Hemoteq
 

Further trademarks of the owner